|
TSN1611 Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Oxaliplatin injection, Paclitaxel (albumin-bound), fluorouracil, leucovorin
Houston, Texas1 trial
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
MD Anderson Cancer Center
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.